Weighing in before the fight - Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy

被引：36

作者：

Denke, MA ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA

来源：

CIRCULATION | 2005年 / 112卷 / 22期

关键词：

editorials; cholesterol; lipoproteins; patients;

D O I：

10.1161/CIRCULATIONAHA.105.588178

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3368 / 3370

页数：3

共 18 条

[1]

Bachorik PS, 1997, CLIN CHEM, V43, P2364

[2] Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels [J].

Ballantyne, CM ;

Andrews, TC ;

Hsia, JA ;

Kramer, JH ;

Shear, C .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :265-269

[3] Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1998-1994) [J].

Gardner, CD ;

Winkleby, MA ;

Fortmann, SP .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (03) :299-304

[4] Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [J].

Gotto, AM ;

Whitney, E ;

Stein, EA ;

Shapiro, DR ;

Clearfield, M ;

Weis, S ;

Jou, JY ;

Langendörfer, A ;

Beere, A ;

Watson, DJ ;

Downs, JR ;

de Cani, JS .

CIRCULATION, 2000, 101 (05) :477-484

[5] Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study [J].

Lamarche, B ;

Moorjani, S ;

Lupien, PJ ;

Cantin, B ;

Bernard, PM ;

Dagenais, GR ;

Despres, JP .

CIRCULATION, 1996, 94 (03) :273-278

[6]

MARCOVINA SM, 1994, CLIN CHEM, V40, P574

[7]

MARCOVINA SM, 1994, CLIN CHEM, V40, P586

[8]

Miremadi S, 2002, CLIN CHEM, V48, P484

[9] Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men [J].

Pischon, T ;

Girman, CJ ;

Sacks, FM ;

Rifai, N ;

Stampfer, MJ ;

Rimm, EB .

CIRCULATION, 2005, 112 (22) :3375-3383

[10] Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study [J].

Sattar, N ;

Williams, K ;

Sniderman, AD ;

D'Agostino, R ;

Haffner, SM .

CIRCULATION, 2004, 110 (17) :2687-2693

← 1 2 →